title: Short- and long-term effects of growth hormone on the heart.
abstract: OBJECTIVE
  To make a critical analysis of using growth hormone (GH) in patients with chronic heart failure and to asses its effects on the heart in long-term replacement.
  
  
  METHODS
  We have studied 27 GHD patients (20 men; mean age: 36+/-15 years; 11 with childhood onset GHD) in a longitudinal, prospective study to assess the effect of GH therapy on the cardiovascular system with a long-term follow-up.
  
  
  RESULTS
  After a mean period of 45.3+/-29.6 months, there were no significant differences in echocardiographic parameters of cardiac structure or function. By contrast, the duration of exercise test improved after treatment (8:19+/-3:27 versus 10:23+/-3:25 min; p=0.01) especially in the subgroup of patients with childhood onset of GH deficiency (7:02+/-4:23 versus 11:33+/-3:07 min; p=0.004) but not in the adult onset GHD subgroup. Systolic blood pressure was significantly higher after treatment in the global group (118+/-18.2 mmHg versus 128+/-17.9 mmHg; p=0.004) and in both subgroups.
  
  
  CONCLUSIONS
  The beneficial effects of GH replacement on the cardiovascular system is suggested but not fully proved and long-term GH substitution in GHD syndrome is not associated with significant changes in cardiac structure or function although these patients exhibit improved exercise capacity.
authors: Patricio
authors: P
authors: Pérez-Berbel
authors: Vicente E
authors: VE
authors: Climent
authors: Antonio
authors: A
authors: Picó
authors: Francisco
authors: F
authors: Marín
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging / Q000517:prevention & control*; D004393:Dwarfism, Pituitary / Q000188:drug therapy*; D004452:Echocardiography; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000187:drug effects*; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D019382:Human Growth Hormone